2000
DOI: 10.1095/biolreprod62.6.1486
|View full text |Cite
|
Sign up to set email alerts
|

Involvement of p38 Mitogen-Activated Protein Kinase Activation in Bromocriptine-Induced Apoptosis in Rat Pituitary GH3 Cells1

Abstract: Bromocriptine, a dopamine D 2 receptor agonist, is a therapeutic agent for patients with prolactinoma and hyperprolactinemia. In this study we demonstrated that bromocriptine induced activation of p38 mitogen-activated protein (MAP) kinase, with concomitant induction of apoptosis in rat pituitary adenoma cell line GH3 cells. Treatment of GH3 cells for 48 h with bromocriptine increased the p38 MAP kinase activity up to 3-to 5-fold and simultaneously increased the number of apoptotic cells. Inclusion in the medi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
33
0

Year Published

2002
2002
2019
2019

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 55 publications
(38 citation statements)
references
References 55 publications
3
33
0
Order By: Relevance
“…In another report, p38 MAP kinase is activated in GH3 cells during bromocryptine-induced apoptosis [26]. The apoptosis of GH3 cells was also observed following treatment with a dopaminergic neurotoxin, 1-methyl-4-phenylpyridinium ion [27], and with inhibitors of serine/threonine phosphatases 1 and 2A [28,29].…”
Section: Discussionmentioning
confidence: 90%
“…In another report, p38 MAP kinase is activated in GH3 cells during bromocryptine-induced apoptosis [26]. The apoptosis of GH3 cells was also observed following treatment with a dopaminergic neurotoxin, 1-methyl-4-phenylpyridinium ion [27], and with inhibitors of serine/threonine phosphatases 1 and 2A [28,29].…”
Section: Discussionmentioning
confidence: 90%
“…PD98059 (10 M and50 M) and GF109203X (5 M), inhibitors of upstream of ERK1/ERK2-MAPK and PKC, 39 respectively, blocked PPF but not adhesion or size increase. While a low dose of SB203580 (10 M), an inhibitor of p38 MAPK 40 and JNK/SAPK 41 pathways, did not affect cell differentiation, a high dose (50 M) of SB blocked the differentiation. Wortmannin (100 nM and 500 nM), an inhibitor of PI3K/Akt pathway, 39 did not affect cell differentiation.…”
Section: Activation Of Erk1/erk2 Is Essential For Full Differentiatiomentioning
confidence: 96%
“…Recently, both D 2S and D 2L receptor isoforms have been demonstrated to activate, through the involvement of G bg subunits and protein kinase C, the mitogen-activated protein kinase (MAPK) and extracellular signal-regulated kinase (ERK) pathway, generally involved in the regulation of cell growth, differentiation and apoptosis (10). In particular, in pituitary tumor cell lines, dopamine agonists have been found to exert a clear anti-proliferative effect, inducing cell death and apoptosis through the D 2 receptor-mediated activation of MAPK and/or ERK pathways (11,12). The main intracellular pathways connected with the activation of dopamine receptors are summarized in Fig.…”
Section: Functional Characteristics Of Dopamine Receptorsmentioning
confidence: 99%